JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heming, A. E.
Right arrow Articles by Holtkamp, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heming, A. E.
Right arrow Articles by Holtkamp, D. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 106, Issue 3, 271-276, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


TECHNIQUE FOR DETECTING THE PHARMACODYNAMICALLY INDUCED ALARM REACTION USING THE EOSINOPENIC RESPONSE OF INTACT RATS

Arthur E. Heming 1, Mary F. Sax 1, and Dorsey E. Holtkamp 1

1 Research and Development Division, Smith, Kline, and French Laboratories, Philadelphia, Pa.

The appropriate selection of commercially obtained, adult, intact, male rats, has provided a means of screening compounds for their pharmacodynamic ability to evoke the alarm reaction. The selection of these rats was based on the following criteria: 1) an initial blood eosinophil count of more than 62 eosinophils per c.mm. blood; 2) an eosinopenic response of less than 15 per cent to an intraperitoneal injection of glucose solution; and 3) an eosinopenic response of greater than 25 per cent to an intraperitoneal injection of epinephrine.

Submitted on June 23, 1952







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.